University of Ioannina
Μελέτη πρωτεϊνών δικτύων ρύθμισης τα οποία εμπλέκονται στον κυτταρικό κύκλο και στην απόπτωση στα διάχυτα λεμφώματα από μεγάλα β-κύτταρα
Abstract
dc:descriptionThe Jun family includes c-Jun, JunB and JunD that are components of the activator protein-1 (AP-1) transcription factor complex involved in cell proliferation and apoptosis. Recent evidence suggests that c-Jun and JunB are expressed in classical Hodgkin lymphomas and CD30-positive non-Hodgkin lymphomas. The STAT family are important transcription factors that have been implicated in cell differentiation, cycle and death. STAT can be activated via the JAK-STAT pathway. Therefore, the immunohistochemical expression of Jun family proteins was studied in relation to: 1) the CD30 expression, 2) the proliferation profile (cyclin A, B1, D2, D3, E and Ki-67) and 3) B cell differentiation markers (CD10, Bcl-6, MUM-1/IRF4) and phenotype in 130 de novo DLBCL. In a subset of cases with low JunB expression, we performed MSP (methylation specific PCR) in order to investigate whether methylation of the JunB promoter correlates with silencing of the gene. Expression of phospho(ph)-c-Jun, JunB, JunD and ph-STAT3 was found in 59/103 (67%), 100/103 (97%), 94/98 (97%) and 41/61 (67%) cases of DLBCL, respectively. The expression of JunB was positively associated with Ki-67 (p=0.032), cyclin A (p=0.042), cyclin B1 (p=0.016), cyclin D2 (p=0.037), cyclin E (p=0.001), CD30 (p<0.001), MUM-1/IRF-4 (p<0.001) and non-GC phenotype (p=0.006) and negatively with CD10 (p<0.001). Moreover, the expression of JunD was positively associated with Ki-67 (p=0.01), cyclin E (p=0.007) and Bcl-6 (p=0.03) as well as the expression of ph-c-Jun with MUM-1/IRF-4 (p=0.03). Cases were also assigned to a high (52 cases) and a low (77 cases) proliferation cluster by K-means clustering based on the combined expression levels of the proteins Ki-67 and cyclin A, B1, D2, D3 and E. These classification variables were ordered by ANOVA according to their statistically significant contribution to the derived clustering from highest to lowest, as follows: Ki-67, cyclin A, cyclin D3, cyclin E and cyclin B1. Cyclin D2 was the only classification variable with statistically non-significant separation ability. Analysis of the differences in mean values between the two clusters by T-tests, showed significantly higher expression levels of the Ki-67, cyclin A, cyclin B1, cyclin D3, cyclin E, bcl6 (all p<0.001), JunB (p=0.033), JunD (p=0.027) and MUM-1/IRF-4 (p=0.006) in the high expression cluster. Methylation of the JunB promoter was found in 17/20 of the cases with low JunB expression. The proteins of Jun family expressed in DLBCL. The association between JunB and JunD and high proliferation cluster in DLBCL, suggests that increased JunB and JunD expression may be involved in their pathogenesis by favoring tumor cell proliferation. The association between JunB and non-GC phenotype may reflect NFκB control of JunB in view of previous findings that JunB is under NFκB control in classical Hodgkin lymphomas and NFκB is activated in non-GC DLBCL. The association between JunD and Bcl-6 expression is in line with data that JunD is a major enhancer molecule of Bcl-6 in mouse GC B-cells. Aberrant methylation of the JunB promoter may be the underlying mechanism in the cases with low JunB expression.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papoudou-Bai, Alexandra
- Παπούδου-Μπάη, Αλεξάνδρα
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/34966